Advantages and Some Remaining Challenges in Hereditary Gastrointestinal Cancer Panel Testing

Specific PHGKB|Cancer|PHGKB

Colorectal Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: May 18, 2017

---

• Advantages and Some Remaining Challenges in Hereditary Gastrointestinal Cancer Panel Testing.  
  Maga Tara et al. Clinical and translational gastroenterology 2017 May 8(5) e92
• Comparison of the efficiency of colorectal cancer screening programs based on age and genetic risk for reduction of colorectal cancer mortality.  
  Stanesby Oliver et al. European journal of human genetics : EJHG 2017 May
• Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.  
  Kastrinos Fay et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 May JCO2016696120
• Differential analysis of mutations in the Jewish population and their implications for diseases.  
  Einhorn Yaron et al. Genetics research 2017 May 99e3
• Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.  
  Rey Jean-Marc et al. The Journal of molecular diagnostics : JMD 2017 May
• Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes.  
  Frey Melissa K et al. Gynecologic oncology 2017 May
• Universal molecular screening does not effectively detect Lynch syndrome in clinical practice.  
  Brennan Beatrice et al. Therapeutic advances in gastroenterology 2017 Apr 10(4) 361-371
• Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.  
  Finney Rutten Lila J et al. Mayo Clinic proceedings 2017 May 92(5) 726-733
• Identifying "ownership" through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch syndrome.  
  West Kathleen M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 May
• Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.  
  O'Kane Grainne M et al. Cancer medicine 2017 May